anti-Kruppel-Like Factor 2 (Lung) (KLF2) Antibodies

Human Kruppel-Like Factor 2 (Lung) (KLF2) interaction partners

1. Suberanilohydroxamic acid has KLF2-dependent anti-inflammatory effects, repressing vascular inflammation and atherosclerosis.

2. we focused on emphasizing the involvement of KLF2 in health and disease states and how they interact with transcriptional master regulator NF-kappaB (show NFKB1 Antibodies).

3. GBP5 and KLF2 may be useful as a diagnostic tool for active tuberculosis, also the two-gene set may serve as surrogate biomarkers for monitoring tuberculosis therapy.

4. Studies indicate that the physiological changes in miR (show MLXIP Antibodies)-200b levels during acute hypoxia may actually have a proangiogenic effect through Klf2 downregulation and subsequent stabilization of HIF-1 (show HIF1A Antibodies) signaling.

5. The flow-mediated miR (show MLXIP Antibodies)-10a expression is regulated by Kruppel-like factor 2 through modulation in RARalpha (show RARA Antibodies)-RARE binding, with the consequent regulation in GATA6 (show GATA6 Antibodies)/VCAM-1 (show VCAM1 Antibodies) in endothelial cells.

6. the effects of omentin (show ITLN1 Antibodies)-1 on KLF2 expression are mediated by p53 (show TP53 Antibodies).

7. ZFAS1 over-expression confers an oncogenic function in gastric cancer and this function is partly dependent on repressing KLF2 and NKD2 (show NKD2 Antibodies)

8. These results indicated that KLF2 plays an important role in colorectal cancer

9. miRNA92a targets KLF2 and PTEN signaling to promote human T follicular helper precursors in type 1 diabetes mellitus islet autoimmunity.

10. Authors found that there was negative correlation between LINC01133 and KLF2, P21 (show CDKN1A Antibodies) or E-cadherin (show CDH1 Antibodies) in NSCLC.

Pig (Porcine) Kruppel-Like Factor 2 (Lung) (KLF2) interaction partners

1. miR (show MYLIP Antibodies)-92a coregulates KLF4 (show KLF4 Antibodies) and KLF2 expression in arterial endothelium and contributes to phenotype heterogeneity associated with regional atherosusceptibility and protection in vivo.

Mouse (Murine) Kruppel-Like Factor 2 (Lung) (KLF2) interaction partners

1. Suberanilohydroxamic acid has KLF2-dependent anti-inflammatory effects, repressing vascular inflammation and atherosclerosis.

2. any one of Klf2, Klf4 (show KLF4 Antibodies) and Klf5 (show KLF5 Antibodies) was sufficient to support self-renewal of mouse embryonic stem cells, whereas the removal of all three compromised it.

3. KLF2 induces an antiproliferative secretome, including activin A (show INHBA Antibodies), which attenuates liver regeneration.

4. miRNA92a targets KLF2 and PTEN signaling to promote human T follicular helper precursors in type 1 diabetes mellitus islet autoimmunity.

5. peripheral tolerance is enhanced or diminished through modulation of Treg trafficking tosecondary lymphoid organs (SLOs (show DHCR7 Antibodies)), a process that can be controlled by adjusting KLF2 protein levels.

6. KLF2 and KLF4 (show KLF4 Antibodies) serve as important regulators that promote hemoglobin alpha (show HBA-A1 Antibodies) expression in the endothelium.

7. Mouse embryos deficient in Orai1 (show TMEM132A Antibodies), Klf2, or Klf4 (show KLF4 Antibodies) showed a significantly reduced lymphatic density and impaired lymphatic development.

8. this study shows that KLF2 governs the degree of dendritic cells activation and hence the intensity of proatherogenic T cell responses

9. Transcription factor Kruppel-like factor 2 (KLF2) of the zinc finger family of DNA-binding proteins has recently emerged as a major molecular switch that controls endothelial homeostasis.

10. A deficiency of KLF2 increased the expression of Notch ligand (show JAG2 Antibodies) Jagged2 (show JAG2 Antibodies) via hypoxia-inducible factor 1alpha (HIF-1alpha (show HIF1A Antibodies)), which led to Th2 amplification.

Xenopus laevis Kruppel-Like Factor 2 (Lung) (KLF2) interaction partners

1. KLF2 and ERG (show ERG Antibodies) associate in a physical complex and the two proteins synergistically activate transcription of Flk1 (show KDR Antibodies).